Riskpilot← Back to searchSign inGet full accessVingmed OY
OYActiveY-tunnus 2790362-1Olarinluoma 12Wholesale of pharmaceutical and medical goods · NACE 4646Est. 201615 employees
Revenue 2024
EUR 8,7M
-6% vs 2023
EBITDA margin
-2.0%
-37% vs 2023
Equity ratio
-104.1%
Financial strength
Net profit 2024
EUR -275K
-7% vs 2023
| Revenue | EUR 8,7M | -6% |
| EBITDA | EUR -170K | -37% |
| Net profit | EUR -275K | -7% |
| Total assets | EUR 2,3M | -16% |
| Equity | EUR -2,4M | -13% |
| Employees | 15 | — |
Legal name
Vingmed OY
Y-tunnus number
2790362-1
Legal form
Osakeyhtiö
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
24. lokakuuta 2016
Share capital
EUR 2 500
Employees
15 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen jäsen yksin
Company purpose
Bolagets verksamhetsområde är försäljning, export, import och underhåll av medicintekniska produkter, laboratorieapparatur och utrustning. Bolaget kan även utöva agenturverksamhet, utförande av marknadsundersökningar, marknadsföring och konsultering.
Address
Olarinluoma 12
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 2 407 | 4 045 | 6 574 | 8 877 | 7 933 | 9 289 | 8 690 |
| Staff expenses | −708 | −1 171 | −1 200 | −1 241 | −1 215 | −1 273 | −1 391 |
| EBITDA | −777 | −733 | 163 | 438 | −313 | −124 | −170 |
| Depreciation & amort. | −9 | −45 | −58 | −63 | −63 | −61 | −43 |
| EBIT | −786 | −778 | 105 | 375 | −376 | −185 | −213 |
| Net financials | −2 | −6 | −17 | −28 | −2 | −72 | −62 |
| Profit before tax | −788 | −784 | 88 | 347 | −378 | −257 | −275 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −788 | −784 | 88 | 347 | −378 | −257 | −275 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 1 368 | 1 499 | 2 889 | 2 080 | 2 438 | 2 749 | 2 313 |
| Equity | 464 | 679 | 896 | −1 497 | 735 | −2 132 | −2 408 |
| Long-term debt | 130 | 165 | 90 | 2 724 | 317 | 350 | 286 |
| Short-term debt | 774 | 655 | 1 904 | 853 | 1 386 | 1 921 | 1 505 |
| Total debt | 904 | 820 | 1 994 | 3 577 | 1 703 | 4 881 | 4 721 |
EBITDA margin
-2.0%
This company
15.8%
Market median
-113% vs market
20182024
Equity ratio
-104.1%
This company
38.2%
Market median
-373% vs market
20182024
Return on equity
-27520600.0%
This company
18.4%
Market median
-149568578% vs market
20182024
Net profit margin
-3.2%
This company
8.1%
Market median
-140% vs market
20182024
Asset turnover
3.76×
This company
1.12×
Market median
+236% vs market
20182024
Debt / equity
1.96×
This company
0.62×
Market median
-216% vs market
20182024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via PRH / YTJ · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JK Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
PP | Audit | 2016 | — | — |
JK Confidential Clerk | Confidential Clerk | 2017 | — | — |
AT Deputy Member | Deputy Member | 2016 | — | — |
JO Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairperson | 2020 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairperson | 2026 | — | — | |
| Board of Directors | 2016 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Vingmed OY also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jyrki Kristian Lönnfors | Chief Executive Officer | 0 companies |
| Pasi Petteri Hirvonen | Audit | 0 companies |
| Jouko Kullervo Niva | Confidential Clerk | 0 companies |
| Andreas Thoresen | Deputy Member | 0 companies |
| Juhamatti Oskari Malm | Chief Executive Officer | 0 companies |
| Jan Erik Kirkeby | Chairperson | 0 companies |
| Jan Holger Gustav Holmberg | Board of Directors | 0 companies |
| Ane Lene Hellevik Asheim | Board of Directors | 0 companies |
| Kolbjørn Haarr | Chairperson | 0 companies |
| Bengt Verner Malmfält | Board of Directors | 0 companies |